<- Go Home

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products.

Market Cap

$435.6M

Volume

2.9M

Cash and Equivalents

$35.6M

EBITDA

-$196.5M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

-$61.0M

Profit Margin

-1674.48%

52 Week High

$3.73

52 Week Low

$0.92

Dividend

N/A

Price / Book Value

1.82

Price / Earnings

-1.55

Price / Tangible Book Value

2.23

Enterprise Value

$231.3M

Enterprise Value / EBITDA

-1.18

Operating Income

-$197.1M

Return on Equity

-94.81%

Return on Assets

-35.69

Cash and Short Term Investments

$310.0M

Debt

$105.7M

Equity

$240.0M

Revenue

$3.6M

Unlevered FCF

-$108.8M

Sector

Biotechnology

Category

N/A

Company Stock Pitches